Zyflo Shortage Update: What Patients Need to Know in 2026

If you've searched online for 'Zyflo shortage 2026' or tried to fill your Zyflo prescription only to find empty shelves, this page is your resource. We track Zyflo availability for patients who depend on zileuton for asthma control and want straight answers about what's happening.

Current Zyflo Availability Status (2026)

As of 2026, Zyflo (zileuton) is NOT on the FDA's official Drug Shortage Database. The drug is manufactured by Chiesi USA, Inc. and is commercially available through pharmaceutical wholesalers. Both the immediate-release (Zyflo) and extended-release (Zyflo CR) formulations are considered active commercial products.

However, 'not in shortage' does not mean 'easy to find.' Many patients report being unable to fill their Zyflo prescriptions at local pharmacies. This is not a supply chain failure — it is a demand and stocking issue that has persisted for years.

Why Do Patients Experience 'De Facto' Shortages?

A drug can be technically available nationally while being practically impossible to find locally. This happens with Zyflo for several interconnected reasons:

Low prescription volume: Zyflo is a second- or third-line medication. Most pharmacies fill only a handful of Zyflo prescriptions per month, making it a low priority for regular stocking.

High cost creates hesitation: With retail prices above $2,800 per 30-day supply, pharmacies are reluctant to tie up capital in a drug that may sit on shelves for weeks. The cost of inventory risk reduces stocking incentives.

Insurance friction: Prior authorization requirements and step therapy policies delay dispensing even when the drug is available. Patients may wait days to weeks for approval, during which time their prescription languishes.

Geographic concentration: Zyflo is prescribed primarily by allergists and pulmonologists in larger metro areas. Pharmacies in smaller towns or rural areas may never receive a Zyflo prescription, so they never stock it.

Has Zyflo Ever Been in a Formal FDA Shortage?

Reviewing the FDA's shortage history, Zyflo has not been listed as an active or resolved shortage in recent years. The drug is a niche product that has never had the broad prescriber adoption needed to generate major shortage news. Its challenges are structural (cost, stocking) rather than supply-chain driven.

This contrasts with medications like Adderall, amoxicillin, or Ozempic that experienced true supply-demand shocks. Zyflo's access problem is chronic and quiet — fewer patients know about it because it affects a smaller population.

Who Is Most Affected by Zyflo Availability Problems?

The patients most likely to struggle with Zyflo availability are:

AERD patients (Aspirin-Exacerbated Respiratory Disease): Zileuton is considered especially effective for AERD, a condition involving sensitivity to aspirin and NSAIDs combined with asthma and nasal polyps. These patients often have no good substitute.

Patients who have failed montelukast: If you've tried and didn't respond to montelukast, Zyflo may be your best remaining oral option for leukotriene control.

Patients in rural or small-market areas: Pharmacies in smaller communities rarely stock Zyflo. If you're not near a major metropolitan area with large chains or specialty pharmacies, you may need to order in advance or use mail-order.

What Patients Should Do Right Now

Don't wait until you're out. Start your refill process 7-10 days early — Zyflo may need to be ordered by your pharmacy.

Use medfinder to quickly find pharmacies that have Zyflo in stock near you, without calling each one yourself.

Ask your prescriber whether a 90-day supply through mail-order is possible — this reduces how often you need to deal with stocking issues.

Apply a GoodRx or SingleCare coupon. Cash-pay prices can drop to $260-$315 per month — sometimes lower than your insurance copay, and available without insurance approval.

If you truly cannot access Zyflo, contact your prescriber immediately. Do not stop asthma medications abruptly. Your doctor can bridge you with an alternative while you locate your supply.

The Bigger Picture: Zyflo and the Drug Access Problem

Zyflo's access challenge is a microcosm of a broader problem in the U.S. pharmaceutical market: niche drugs that serve a small but medically dependent population face chronic access issues, not because they don't exist, but because the economics of pharmacy stocking work against them. Patients who need these medications most often have no good substitute — and face the highest barriers.

For detailed steps on locating Zyflo, read: How to Find Zyflo in Stock Near You (Tools + Tips)